We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-14.14%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$360M
AUM Growth
-$46.9M
Cap. Flow
-$5.57M
Cap. Flow %
-1.55%
Top 10 Hldgs %
13.59%
Holding
339
New
120
Increased
41
Reduced
71
Closed
90

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$6.24M
2
ADBE icon
Adobe
ADBE
+$5.65M
3
NVDA icon
NVIDIA
NVDA
+$5.46M
4
EA icon
Electronic Arts
EA
+$5.33M
5
GS icon
Goldman Sachs
GS
+$5.21M

Top Sells

Rank Stock Value
1
QLYS icon
Qualys
QLYS
+$10.4M
2
HDP
Hortonworks, Inc.
HDP
+$9.34M
3
CW icon
Curtiss-Wright
CW
+$7.91M
4
ADAP
Adaptimmune Therapeutics
ADAP
+$7.67M
5
XLRN
Acceleron Pharma
XLRN
+$7.16M

Sector Composition

Rank Sector Weight
1 Technology 17.65%
2 Industrials 15.24%
3 Healthcare 12.96%
4 Consumer Discretionary 6.56%
5 Financials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ST icon
226
Sensata Technologies
ST
$6.65B
– –
-100,545
Closed -$4.98M
SXT icon
227
Sensient Technologies
SXT
$5.4B
– –
-2,667
Closed -$204K
TMO icon
228
Thermo Fisher Scientific
TMO
$211B
– –
-28,244
Closed -$6.89M
TPIC
229
DELISTED
TPI Composites
TPIC
– –
-51,726
Closed -$1.48M
TRMB icon
230
Trimble
TRMB
$12.3B
– –
-141,992
Closed -$6.17M
UPS icon
231
United Parcel Service
UPS
$97.6B
– –
-7,477
Closed -$873K
VEA icon
232
Vanguard FTSE Developed Markets ETF
VEA
$226B
– –
-12,202
Closed -$528K
VSEC icon
233
VSE Corp
VSEC
$5.48B
– –
-16,698
Closed -$553K
WHG icon
234
Westwood Holdings Group
WHG
$182M
– –
-10,255
Closed -$531K
ZYME icon
235
Zymeworks
ZYME
$1.68B
– –
-56,490
Closed -$887K
BERY
236
DELISTED
Berry Global Group, Inc.
BERY
– –
-75,303
Closed -$3.35M
CYAD
237
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
– –
-39,750
Closed -$1.05M
ALBO
238
DELISTED
Albireo Pharma Inc
ALBO
– –
-32,788
Closed -$1.08M
ECOL
239
DELISTED
US Ecology, Inc.
ECOL
– –
-15,811
Closed -$1.17M
KSU
240
DELISTED
Kansas City Southern
KSU
– –
-50,653
Closed -$5.74M
XLRN
241
DELISTED
Acceleron Pharma
XLRN
– –
-125,020
Closed -$7.16M
TRIL
242
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-139,403
Closed -$809K
PFPT
243
DELISTED
Proofpoint, Inc.
PFPT
– –
-60,706
Closed -$6.46M
CBPX
244
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
– –
-41,619
Closed -$1.56M
RTEC
245
DELISTED
Rudolph Technologies Inc
RTEC
– –
-30,921
Closed -$756K
BRSS
246
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
– –
-24,481
Closed -$903K
HF
247
DELISTED
HFF Inc.
HF
– –
-17,869
Closed -$759K
IMPV
248
DELISTED
Imperva, Inc.
IMPV
– –
-109,507
Closed -$5.09M
HDP
249
DELISTED
Hortonworks, Inc.
HDP
– –
-409,408
Closed -$9.34M
PX
250
DELISTED
Praxair Inc
PX
– –
-18,351
Closed -$2.95M
7 8 9
10
11

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2018 Portfolio in Review

As of Q4 2018, Stanley-Laman Group held 339 positions worth $360M, down 12% from $407M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Stanley-Laman Group's Q4 2018 filing shows 120 new, 41 increased, 71 reduced and 90 closed positions. Its largest new stake was New Relic, Inc.: 74,133 shares worth $6M. The largest sale was Qualys, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2018 buy was New Relic, Inc.: 74,133 shares worth $6M.
  • Stanley-Laman Group added most to Raytheon Company in Q4 2018, an estimated $4.87M increase.
  • Stanley-Laman Group's biggest Q4 2018 reduction was Tiffany & Co., cutting an estimated $1.02M.
  • Stanley-Laman Group fully exited Qualys in Q4 2018, selling an estimated $10.4M.
  • Stanley-Laman Group's ten largest holdings make up 14% of its $360M portfolio in Q4 2018.
  • Stanley-Laman Group opened 120 new positions and closed 90 in Q4 2018.
  • Stanley-Laman Group's portfolio value fell 12% quarter-over-quarter to $360M.

Based on Stanley-Laman Group's 13F filing for Q4 2018, filed 7 Feb 2019.